文献速递口腔修复与种植口腔颌面外科

异种骨/自体骨与胶原稳定异种骨在上颌窦提升术中的前瞻性对照试验:并发症、患者报告结局与体积分析

A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation-Complications, patient-reported outcomes and volumetric analysis.
PubMed 文献 · Clin Oral Implants Res · 2017-12-12

两组并发症均轻微,自体骨采集组患者报告不适更明显;胶原稳定异种骨可获得与联合组相当的骨体积,足以植入合适尺寸种植体。移植物与窦壁接触程度对骨体积有显著正向影响。

要点

  • 上颌窦提升采用侧壁入路安全,术后48-72小时仅有轻中度疼痛和日常活动受限。
  • 自体骨采集增加患者报告的不适,但两组并发症均为轻微且未影响后续种植。
  • 胶原稳定异种骨可获得与自体骨+异种骨相当的骨体积,无需额外垂直骨增量。

核心结论

  • 侧壁入路上颌窦提升安全,术后48-72小时有轻中度疼痛和日常活动限制。
  • 自体骨采集患者报告的不适更明显。
  • 胶原稳定异种骨可获得与自体骨+异种骨相当的骨体积,足以植入合适尺寸种植体而无需额外垂直骨增量。
  • 移植物与周围窦壁接触对骨体积有显著正向影响。

研究设计与样本

  • 记录术中及术后并发症,采用患者报告结局指标评估移植对日常活动、疼痛和不适的影响,CT扫描测量移植物体积、嵴高度、材料选择及移植体与周围窦壁接触程度,并记录种植体植入参数。

主要发现

  • 所有并发症均为轻微,未妨碍完成上颌窦提升或后续种植体植入。
  • 施耐德膜穿孔是最常见的并发症。
  • 两组术后48小时内均报告中度受限,第3或4天时报告很少或无受限。
  • 对照组在张口、咀嚼和瘀伤方面显著更高。
  • 对工作和社会生活的影响初期为中度,第2天降至很少或无;前3天报告轻中度疼痛和日常活动干扰,仅需使用非甾体抗炎药。

关键数值与推荐

  • 对照组平均移植物体积1.46 cm³(±0.77),试验组1.27 cm³(±0.65)。
  • 试验组更频繁使用8 mm短种植体,更可能需要额外垂直骨增量,但无统计学显著性。
  • 移植物与周围窦壁接触程度对骨体积有显著影响。

临床怎么用

  • 上颌窦提升采用侧壁入路时,可预期术后48-72小时轻中度疼痛和日常活动受限,仅需非甾体抗炎药。
  • 使用胶原稳定异种骨可避免自体骨采集相关不适,并获得足以植入合适尺寸种植体的骨体积。
  • 术中应尽量使移植物与周围窦壁充分接触,以利于获得更大骨体积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Compare maxillary sinus augmentation (MSA) using two different materials-anorganic bovine bone mineral (ABBM) + autogenous bone (AB) (control group) vs. collagen-stabilized ABBM (test group) in terms of complications, patient-reported outcome measures (PROMs) and volumetric analysis. MATERIALS AND METHODS: Sixty patients underwent sinus augmentation (30 control + 30 test group). Intra- and postoperative complications were recorded. PROMs measured the impact of grafting on daily activities, pain and morbidity. CT scans were used to measure graft volume, ridge height, material selection and degree of contact of graft-to-surrounding sinus walls. Dental implant placement parameters were also recorded. RESULTS: All complications were minor and did not prevent completion of the augmentation or subsequent implant placement. Schneiderian membrane perforation was the most frequently encountered complication. Both treatment groups reported moderate limitation in the 1st 48 hr post-surgery but little or none by day 3 or 4. Jaw opening, chewing and bruising were significantly higher in the control group. The impact on work and social life was moderate initially but reduced to little or none by the 2nd day. Mild to moderate pain and interference to daily activities were reported for the first 3 days requiring the use of NSAIDs only. A mean graft volume of 1.46 cm3 (±0.77) was calculated in the control group and 1.27 cm3 (±0.65) in the test group. Extent of contact between graft and surrounding sinus walls had a significant impact on bone volume. Shorter (8 mm) implants were utilized more frequently in the test group, which was also more likely to require additional vertical augmentation, but this was not statistically significant. CONCLUSION: MSA using a lateral wall approach is safe and associated with mild to moderate pain and restrictions to daily activities for 48-72 hr. Patients' reports of morbidity were greater with autogenous bone harvesting. Collagen-stabilized ABBM provides comparable bone volume to AB + ABBM that is sufficient for placement of implants of adequate size with no need for further vertical augmentation. Engaging the surrounding sinus walls had a significant positive impact on graft volume.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Alayan J, Ivanovski S. A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation-Complications, patient-reported outcomes and volumetric analysis. Clin Oral Implants Res. 2017. PMID: 29231263. doi:10.1111/clr.13107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。